Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

VERTEX PHARMACEUTICALS

Filed by TIBER CREEK GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2025
Income
$60,000.00
Expenses
Not reported
Filing UUID
a881401b-3d5e-4d1e-9677-9305c3463806
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.

Literal federal measure citations: H.R. 1227, S. 475

DEF · Defense

Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Literal federal measure citations: H.R. 3838, S. 2296

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.